Skip to content

Efficacy of Japanese osteoporosis liaison service for secondary fracture prevention

Efficacy of Japanese osteoporosis liaison service for secondary fracture prevention - JOLS study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032892
Enrollment
1400
Registered
2018-06-06
Start date
2018-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

Osteoporosis liaison service within 3 months after the fracture. In addition, the researchers remind the patients of the importance of the treatment at 6, 12 and 24 months after the fracture.

Sponsors

Fujita Health University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Postmenopausal women or male equal to or over 50 years old 2. Primary osteoporosis 3. Admission in hospital due to new clinical vertebral fracture or hip fracture

Exclusion criteria

Exclusion criteria: 1. Bone metabolic diseases including primary hyperparathyroidism 2. Patients on hemodialysis and after kidney transplantation 3.Unwillingness to participate the study 4. Inappropriate patients due to clinical information

Design outcomes

Primary

MeasureTime frame
Clinical fragile fracture during 24 months after osteoporotic fracture

Countries

Japan

Contacts

Public ContactAtsushi Suzukui

Fujita Health University Department of Endocrinology and Metabolism

aslapin@fujita-hu.ac.jp0562939242

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026